The parents of brave Esha Nadeswaran are urging people to keep an eye out for symptoms of acute myeloid leukaemia ...
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a ...
Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...
My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...
In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...
Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results